Joseph Payne

President & CEO at Arcturus Therapeutics

Speaker

Joseph Payne is the President and Chief Executive Officer of Arcturus Therapeutics (NASDAQ: ARCT). He has served on Arcturus’s Board since its founding in 2013. During his tenure, Arcturus has built a diverse pipeline of seven (7) RNA medicines, and established multiple pharmaceutical partnerships globally with potential value totaling over $2 Billion. Prior to Arcturus, Joseph’s background includes successful pharma experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto as evidenced by over 40 publications and patents, and several investigational new drug (IND) clinical candidates. His academic training includes a Bachelor's Degree in Chemistry, magna cum laude from Brigham Young University, a Master of Science in Synthetic Organic Chemistry from the University of Calgary and Executive Training Certification from MIT Sloan School of Management.